- Home
- OKYO vs FOXX Comparison
OKYO vs FOXX Comparison
Compare OKYO & FOXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OKYO
- FOXX
- Stock Information
- Founded
- OKYO 2007
- FOXX 2017
- Country
- OKYO United Kingdom
- FOXX United States
- Employees
- OKYO N/A
- FOXX N/A
- Industry
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- FOXX
- Sector
- OKYO Health Care
- FOXX
- Exchange
- OKYO Nasdaq
- FOXX Nasdaq
- Market Cap
- OKYO 37.0M
- FOXX 33.5M
- IPO Year
- OKYO 2022
- FOXX N/A
- Fundamental
- Price
- OKYO $1.19
- FOXX $4.92
- Analyst Decision
- OKYO Strong Buy
- FOXX
- Analyst Count
- OKYO 1
- FOXX 0
- Target Price
- OKYO $7.00
- FOXX N/A
- AVG Volume (30 Days)
- OKYO 143.7K
- FOXX 20.6K
- Earning Date
- OKYO 04-08-2025
- FOXX 05-15-2025
- Dividend Yield
- OKYO N/A
- FOXX N/A
- EPS Growth
- OKYO N/A
- FOXX N/A
- EPS
- OKYO N/A
- FOXX N/A
- Revenue
- OKYO N/A
- FOXX $42,988,015.00
- Revenue This Year
- OKYO N/A
- FOXX N/A
- Revenue Next Year
- OKYO N/A
- FOXX N/A
- P/E Ratio
- OKYO N/A
- FOXX N/A
- Revenue Growth
- OKYO N/A
- FOXX 98.81
- 52 Week Low
- OKYO $0.81
- FOXX $2.45
- 52 Week High
- OKYO $1.74
- FOXX $14.99
- Technical
- Relative Strength Index (RSI)
- OKYO 45.06
- FOXX N/A
- Support Level
- OKYO $1.31
- FOXX N/A
- Resistance Level
- OKYO $1.48
- FOXX N/A
- Average True Range (ATR)
- OKYO 0.11
- FOXX 0.00
- MACD
- OKYO -0.03
- FOXX 0.00
- Stochastic Oscillator
- OKYO 17.07
- FOXX 0.00
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
About FOXX Foxx Development Holdings Inc. Common Stock
Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals.